Pantel et al.
2019
Circulating tumor cells in prostate cancer: from discovery to clinical utility
Sinn et al.
2017
Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer
Van Treijen et al.
2018
Blood transcript profiling for the detection of neuroendocrine tumors: results of a large independent validation study
US20130059747A1
(en )
2013-03-07
Multigene prognostic assay for lung cancer
Tadmor et al.
2015
Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: evaluation based on data from 1450 patients
Ahn et al.
2013
Preoperative serum tissue polypeptide‐specific antigen is a valuable prognostic marker in breast cancer
Adams et al.
2015
Prognostic value of anemia and C-reactive protein levels in diffuse large B-cell lymphoma
Charmsaz et al.
2017
S100β as a serum marker in endocrine resistant breast cancer
EP3465215B1
(en )
2021-03-03
Method of prognosing and predicting breast cancer recurrence, markers employed therein and kit thereof
Honing et al.
2015
CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy
Portier et al.
2013
HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma
Ma et al.
2014
Overexpression of GOLPH3 protein is associated with worse prognosis in patients with epithelial ovarian cancer
JP2013532489A5
(enExample )
2014-09-04
Wei et al.
2017
MiR-1, a potential predictive biomarker for recurrence in prostate cancer after radical prostatectomy
Browne et al.
2019
MicroRNA expression profiles in upper tract urothelial carcinoma differentiate tumor grade, stage, and survival: implications for clinical decision-making
Luo et al.
2012
Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma
Zhuang et al.
2016
How precisely can prostate cancer be managed?
Cai et al.
2012
High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma
Chen et al.
2014
Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer
Zheng et al.
2015
Critical evaluation of Cbx7 downregulation in primary colon carcinomas and its clinical significance in Chinese patients
Trebinska-Stryjewska et al.
2019
Cytoplasmic HAX1 is an independent risk factor for breast cancer metastasis
JP5403534B2
(ja )
2014-01-29
食道癌の予後予測のための情報を提供する方法
US7951544B1
(en )
2011-05-31
Method for determining the prognosis of cancer patients by measuring levels of bag expression
JP2021019612A
(ja )
2021-02-18
治療剤に対する抵抗性の診断に使用するためのＥＲＣＣ１アイソフォーム３のｍＲＮＡおよび／またはタンパク質ならびにこのｍＲＮＡおよび／またはタンパク質を使用する治療剤に対する抵抗性を診断するための方法
Fisher et al.
2016
CD151 gene and protein expression provides independent prognostic information for patients with adenocarcinoma of the esophagus and gastroesophageal junction treated by esophagectomy